THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 98 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 6.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $203,000 | -11.4% | 9,636 | -4.5% | 0.00% | -33.3% |
| Q1 2019 | $229,000 | -59.0% | 10,088 | -27.9% | 0.01% | -14.3% |
| Q2 2017 | $558,000 | -26.3% | 13,995 | -31.9% | 0.01% | -22.2% |
| Q1 2017 | $757,000 | +76.0% | 20,558 | +52.5% | 0.01% | +125.0% |
| Q4 2016 | $430,000 | -8.7% | 13,478 | +3.7% | 0.00% | -33.3% |
| Q3 2016 | $471,000 | +84.7% | 13,001 | +15.7% | 0.01% | +100.0% |
| Q2 2016 | $255,000 | – | 11,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |